ctrl K

AI Score

Unlock

ArriVent BioPharma Inc. C... (AVBP)

AI Score

Unlock

20.25

0.73 (3.74%)

At close: Mar 24, 2025, 2:48 PM

ArriVent BioPharma Common Stock Income Statement

Table Mode

Year	FY23	FY22	FY21
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-74.59M	-36.91M	-8.7M
Interest Income	5.26M	n/a	n/a
Pretax Income	-69.33M	-36.91M	-51.61M
Net Income	-69.33M	-36.91M	-51.61M
Selling & General & Admin	9.71M	6.47M	2.26M
Research & Development	64.88M	30.43M	6.43M
Other Expenses	n/a	n/a	n/a
Operating Expenses	74.59M	36.91M	8.7M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-754K
Cost & Expenses	74.59M	36.91M	8.7M
Income Tax	n/a	-36.91M	-11.59M
Shares Outstanding (Basic)	31.96M	33.49M	33.49M
Shares Outstanding (Diluted)	31.96M	33.49M	33.49M
EPS (Basic)	-2.17	-1.1	-1.54
EPS (Diluted)	-2.17	-1.1	-1.54
EBITDA	-74.59M	-36.91M	-51.61M
Depreciation & Amortization	n/a	36.91M	11.59M